☆ 4.1 Editorial Material

Ibrutinib-related uveitis: A report of two severe cases

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Ophthalmology

Ophthalmic involvement of chronic lymphocytic leukemia: A systematic review of 123 cases

Florence Delestre et al.

Summary: The study identified clinical presentations, main causes, and prognosis of ophthalmic involvement in chronic lymphocytic leukemia (CLL) by analyzing 86 articles describing 123 cases. The main causes of ophthalmic features were CLL-infiltration, lymphoma, and infection, each with specific clinical and radiological characteristics. The prognosis was generally poor, with eye infections associated with the poorest outcomes.

SURVEY OF OPHTHALMOLOGY (2021)

添加到收藏夹

Review Ophthalmology

Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis

Sara Touhami et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2019)

添加到收藏夹

Article Oncology

Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions

Chen Fu et al.

ONCOTARGET (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Drug-induced uveitis

Miguel Cordero-Coma et al.

EXPERT OPINION ON DRUG SAFETY (2015)

添加到收藏夹

Article Medicine, General & Internal

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

J. C. Byrd et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Hematology

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky et al.

BLOOD (2013)

添加到收藏夹

Editorial Material Medicine, General & Internal

Retinal complications associated with hyperviscosity in chronic lymphocytic leukaemia

C. E. F. Davies et al.

INTERNAL MEDICINE JOURNAL (2008)

添加到收藏夹

Article Ophthalmology

The prevalence of ocular disease in chronic lymphocytic leukaemia

J Buchan et al.

EYE (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.